IL-6 signaling via α- and β-receptors (IL-6R and gp130) is an important biological process for cell differentiation and proliferation, tissue homeostasis, and, when dysregulated, crucial for the onset and progression of certain pathological conditions, such as rheumatoid arthritis and cancer [14,15,16,17,18]. The gene discussed is IL6R; the disease is cancer.